Institutional members access full text with Ovid®

Share this article on:

Menopausal transition stage–specific changes in circulating adrenal androgens

McConnell, Daniel S. PhD1; Stanczyk, Frank Z. PhD2; Sowers, MaryFran R. PhD1; Randolph, John F. Jr MD3; Lasley, Bill L. PhD4

doi: 10.1097/gme.0b013e31823fe274
Original Articles

Objective: It is now recognized that mean circulating dehydroepiandrosterone sulfate (DHEAS) concentrations in most midlife women exhibit a positive inflection starting in early perimenopause, continuing through early postmenopause and returning to early perimenopausal levels by late postmenopause. This rise in mean DHEAS is accompanied by concomitant rises in testosterone (T), dehydroepiandrosteone (DHEA), and androstenedione (Adione) and an equal rise in androstenediol (Adiol). These observations suggest that there is a specific relationship between the circulating levels of steroids emanating from the adrenal glands, declining ovarian function, and the stages of the menopausal transition. This study was designed to test the hypothesis that the menopausal stage–specific change in circulating DHEAS is associated with concomitant changes in the circulating pattern of adrenal steroids and that some of these adrenal androgens could influence the circulating estrogen/androgen balance.

Methods: Stored annual serum samples (N = 120) were first selected to represent four longitudinal DHEAS profiles of individual women to assess and compare changes in the adrenal contribution to circulating steroids.

Results: Changes in mean circulating DHEAS levels in midlife women during the menopausal transition is associated with changes in mean circulating T, Adione, and Adiol. Mean Adione and T concentrations changed the least, whereas mean DHEAS and Adiol changed the most.

Conclusions: Changes in circulating steroid hormone emanating from the adrenal during the menopausal transition may be more important than the decline in ovarian function in terms of altering the estrogen/androgen balance.

Changes in circulating steroid hormone emanating from the adrenal during the menopausal transition may be more important than the decline in ovarian function in terms of altering the estrogen-androgen balance.

From the 1Department of Epidemiology, The University of Michigan, Ann Arbor, MI; 2Departments of Obstetrics/Gynecology and Preventive Medicine, USC Keck School of Medicine, Los Angeles, CA; 3Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI; and 4Center for Health and the Environment, University of California, Davis, CA.

Received August 18, 2011; revised and accepted November 1, 2011.

Funding/support: The Study of Women’s Health Across the Nation (SWAN) has grant support from the National Institutes of Health (NIH), Department of Health and Human Services, through the National Institute on Aging (NIA), the National Institute of Nursing Research (NINR), and the NIH Office of Research on Women’s Health (ORWH; Grants NR004061; AG012505, AG012535, AG012531, AG012539, AG012546, AG012553, AG012554, AG012495).

The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NIA, NINR, ORWH, or NIH.

Financial disclosure/conflicts of interest: None reported.

Address correspondence to: Daniel S. McConnell, PhD, Department of Epidemiology, The University of Michigan, 109 Observatory, SPH1 Rm 1867, Ann Arbor, MI 48109-2029. E-mail: DanMcC@umich.edu

©2012The North American Menopause Society